8-K Announcements
6Material company update
Apr 29, 2026·SEC
Material company update
Apr 1, 2026·SEC
Material company update
Mar 31, 2026·SEC
Femasys Inc.(FEMY)Earnings, Financials & Key Ratios
FEMY•NASDAQ
$0.45
$13M mkt cap·Price updated May 7, 2026
AboutFemasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. It also commercializes FemVue saline-air device in the United States, Europe, Canada, Japan, and internationally. The company offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. In addition, it provides non-surgical product technologies. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia.Show more
- Revenue$2M+40.8%
- EBITDA-$17M+1.0%
- Net Income-$19M+1.0%
- EPS (Diluted)-0.47+44.0%
- Gross Margin61.96%-6.9%
- EBITDA Margin-729.87%+29.7%
- Operating Margin-766.95%+29.8%
- Net Margin-812.27%+29.7%
- ROE-455.8%-150.2%
- ROIC-347.38%-25.4%
- Debt/Equity0.80-75.2%
- Interest Coverage-8.85+17.5%
FEMY Key Insights
Femasys Inc. (FEMY) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong 5Y sales CAGR of 17.2%
✗Weaknesses
- ✗Profits declining 21.9% over 5 years
- ✗Weak Piotroski F-Score: 2/9
- ✗Negative free cash flow
- ✗Weak momentum: RS Rating 9 (bottom 9%)
- ✗Shares diluted 77.6% in last year
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
FEMY Price & Volume
Femasys Inc. (FEMY) stock price & volume — 10-year historical chart
Loading chart...
FEMY Growth Metrics
Femasys Inc. (FEMY) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years17.18%
3 Years23.88%
TTM40.77%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM1%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM33.77%
Return on Capital
10 Years-94.46%
5 Years-94.51%
3 Years-121.62%
Last Year-167.91%
FEMY Peer Comparison
Femasys Inc. (FEMY) competitors in Surgical and interventional devices — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 CODA | 134.12M | 11.90 | 32.16 | 30.75% | 14.78% | 7.17% | 0.01 | |
 BLFS | 1.13B | 23.12 | -92.48 | 16.97% | -10.52% | -2.91% | 0.05 | |
 XWEL | 7.06M | 1.27 | -0.25 | -13.83% | -58.17% | |||
 HOLO | 2.51M | 1.72 | -0.27 | 42.62% | 91.92% | 10.3% | 0.00 | |
 SSKN | 6.66M | 0.18 | -0.67 | 0.61% | -35.64% | -8.4% | 3.31 | |
 TELA | 44.38M | 1.10 | -0.83 | 18.56% | -50.61% | -272.13% | 1.51 | |
 NXRT | 756.27M | 29.80 | -23.65 | -3.24% | -12.67% | -10.13% | 5.18 | |
 HOLX | 16.97B | 76.01 | 30.53 | 1.74% | 13.18% | 11.01% | 0.52 |
Compare FEMY vs Peers
Femasys Inc. (FEMY) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
FEMY Income Statement
Femasys Inc. (FEMY) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|
| Sales/Revenue | 929.06K | 1.04M | 1.18M | 1.21M | 1.07M | 1.63M | 2.29M |
| Revenue Growth % | - | 11.72% | 13.66% | 2.25% | -11.13% | 51.97% | 40.77% |
| Cost of Goods Sold | 223.68K | 306.53K | 370.38K | 441.94K | 380.07K | 544.9K | 872.4K |
| COGS % of Revenue | 24.08% | 29.53% | 31.4% | 36.64% | 35.46% | 33.45% | 38.04% |
| Gross Profit | 705.39K▲ 0% | 731.38K▲ 3.7% | 809.3K▲ 10.7% | 764.28K▼ 5.6% | 691.9K▼ 9.5% | 1.08M▲ 56.7% | 1.42M▲ 31.1% |
| Gross Margin % | 75.92% | 70.47% | 68.6% | 63.36% | 64.54% | 66.55% | 61.96% |
| Gross Profit Growth % | - | 3.69% | 10.65% | -5.56% | -9.47% | 56.7% | 31.06% |
| Operating Expenses | 12.34M | 7.66M | 9.15M | 12.36M | 15.2M | 18.87M | 19.01M |
| OpEx % of Revenue | 1328.5% | 738.45% | 775.3% | 1025.07% | 1417.98% | 1158.3% | 828.91% |
| Selling, General & Admin | 4.8M | 2.85M | 4.47M | 5.99M | 7.51M | 10.36M | 11.09M |
| SG&A % of Revenue | 516.93% | 275% | 378.98% | 496.56% | 700.41% | 635.69% | 483.57% |
| Research & Development | 6.91M | 4.13M | 4.08M | 5.81M | 7.21M | 8.22M | 7.58M |
| R&D % of Revenue | 744.21% | 397.97% | 346.22% | 481.98% | 672.47% | 504.36% | 330.43% |
| Other Operating Expenses | 625.78K | 679.65K | 591.07K | 561.23K | 483.48K | 297.32K | 342.03K |
| Operating Income | -11.64M▲ 0% | -6.93M▲ 40.4% | -8.34M▼ 20.2% | -11.6M▼ 39.1% | -14.51M▼ 25.1% | -17.79M▼ 22.6% | -17.59M▲ 1.1% |
| Operating Margin % | -1252.57% | -667.99% | -706.7% | -961.71% | -1353.43% | -1091.75% | -766.95% |
| Operating Income Growth % | - | 40.42% | -20.25% | -39.15% | -25.07% | -22.59% | 1.11% |
| EBITDA | -10.54M | -5.83M | -7.37M | -10.71M | -13.6M | -16.91M | -16.74M |
| EBITDA Margin % | -1134.75% | -561.93% | -624.95% | -887.99% | -1268.73% | -1038.22% | -729.87% |
| EBITDA Growth % | - | 44.68% | -26.41% | -45.28% | -26.97% | -24.36% | 1.04% |
| D&A (Non-Cash Add-back) | 1.09M | 1.1M | 964.29K | 889.14K | 907.99K | 872K | 850.46K |
| EBIT | -11.26M | -6.9M | -7.51M | -11.37M | -14.08M | -17.2M | -16.74M |
| Net Interest Income | 277.56K | 9.95K | -15.46K | 214.7K | 265.63K | -1.02M | -1.79M |
| Interest Income | 287.54K | 22.5K | 3.77K | 228.16K | 431.02K | 582.35K | 101.76K |
| Interest Expense | 9.97K | 12.55K | 19.23K | 13.46K | 165.39K | 1.6M | 1.89M |
| Other Income/Expense | 368.24K | 19.95K | 802.96K | 212.39K | 265.63K | -1.02M | -1.04M |
| Pretax Income | -11.27M▲ 0% | -6.91M▲ 38.7% | -7.53M▼ 9.0% | -11.39M▼ 51.2% | -14.24M▼ 25.1% | -18.81M▼ 32.0% | -18.63M▲ 1.0% |
| Pretax Margin % | -1212.93% | -666.06% | -638.63% | -944.1% | -1328.66% | -1154.44% | -812.21% |
| Income Tax | 3.01K | 1.8K | 4K | 6.3K | 4.34K | 9.6K | 1.3K |
| Effective Tax Rate % | -0.03% | -0.03% | -0.05% | -0.06% | -0.03% | -0.05% | -0.01% |
| Net Income | -11.27M▲ 0% | -6.91M▲ 38.7% | -7.54M▼ 9.0% | -11.39M▼ 51.2% | -14.25M▼ 25.0% | -18.82M▼ 32.1% | -18.63M▲ 1.0% |
| Net Margin % | -1213.26% | -666.24% | -638.97% | -944.62% | -1329.06% | -1155.03% | -812.27% |
| Net Income Growth % | - | 38.65% | -9.01% | -51.16% | -25.04% | -32.07% | 1% |
| Net Income (Continuing) | -11.27M | -6.91M | -7.54M | -11.39M | -14.25M | -18.82M | -18.63M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.96▲ 0% | -0.59▲ 38.5% | -0.64▼ 8.5% | -0.97▼ 51.6% | -0.93▲ 4.1% | -0.84▲ 9.7% | -0.47▲ 44.0% |
| EPS Growth % | - | 38.54% | -8.47% | -51.56% | 4.12% | 9.68% | 44.05% |
| EPS (Basic) | -0.96 | -0.59 | -0.64 | -0.97 | -0.93 | -0.84 | -0.47 |
| Diluted Shares Outstanding | 11.76M | 11.76M | 11.8M | 11.8M | 15.38M | 22.27M | 39.55M |
| Basic Shares Outstanding | 11.76M | 11.76M | 11.8M | 11.8M | 15.38M | 22.27M | 39.55M |
| Dividend Payout Ratio | - | - | - | - | - | - | - |
FEMY Balance Sheet
Femasys Inc. (FEMY) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|
| Total Current Assets | 8.04M | 3.86M | 25.63M | 14.13M | 23.18M | 8.02M | 16.46M |
| Cash & Short-Term Investments | 7.41M | 3.32M | 24.78M | 12.96M | 21.72M | 3.45M | 9.27M |
| Cash Only | 6.42M | 3.32M | 24.78M | 12.96M | 21.72M | 3.45M | 9.27M |
| Short-Term Investments | 998.83K | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 83.55K | 125.79K | 84.26K | 77.47K | 98.91K | 488.37K | 616.6K |
| Days Sales Outstanding | 32.83 | 44.24 | 26.07 | 23.44 | 33.68 | 109.42 | 98.14 |
| Inventory | 172.5K | 131.38K | 208.27K | 436.72K | 667.12K | 3.05M | 5.74M |
| Days Inventory Outstanding | 281.48 | 156.44 | 205.24 | 360.69 | 640.67 | 2.04K | 2.4K |
| Other Current Assets | 370.02K | 284.12K | 555.85K | 655.36K | 695.88K | 1.04M | 833.13K |
| Total Non-Current Assets | 4.61M | 3.74M | 2.95M | 2.76M | 4.58M | 4.42M | 4.27M |
| Property, Plant & Equipment | 3.86M | 2.89M | 2.26M | 1.8M | 3.49M | 3.4M | 3.19M |
| Fixed Asset Turnover | 0.24x | 0.36x | 0.52x | 0.67x | 0.31x | 0.48x | 0.72x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 160.59K | 65.07K | 25.09K | 3.29K | 0 | 65.92K | 134.91K |
| Long-Term Investments | 0 | 0 | -20.38M | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 583.5K | 792.44K | 655.42K | 958.18K | 1.09M | 954.99K | 940.23K |
| Total Assets | 12.65M▲ 0% | 7.61M▼ 39.9% | 28.58M▲ 275.7% | 16.9M▼ 40.9% | 27.76M▲ 64.3% | 12.45M▼ 55.2% | 20.72M▲ 66.5% |
| Asset Turnover | 0.07x | 0.14x | 0.04x | 0.07x | 0.04x | 0.13x | 0.11x |
| Asset Growth % | - | -39.85% | 275.7% | -40.88% | 64.28% | -55.16% | 66.53% |
| Total Current Liabilities | 1.29M | 2.89M | 1.69M | 1.53M | 3.05M | 8.58M | 3.64M |
| Accounts Payable | 481.1K | 674.33K | 445.52K | 510.76K | 1.14M | 1.42M | 1.83M |
| Days Payables Outstanding | 785.06 | 802.95 | 439.05 | 421.84 | 1.09K | 950.54 | 765.7 |
| Short-Term Debt | 0 | 630.01K | 181.12K | 141.3K | 0 | 5.41M | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 32.9K | 54.98K | 416.73K | 1.15M | 88.58K | 923.55K |
| Current Ratio | 6.25x | 1.34x | 15.15x | 9.25x | 7.59x | 0.93x | 4.53x |
| Quick Ratio | 6.12x | 1.29x | 15.02x | 8.96x | 7.37x | 0.58x | 2.95x |
| Cash Conversion Cycle | -470.75 | -602.28 | -207.73 | -37.7 | -418.37 | 1.2K | 1.73K |
| Total Non-Current Liabilities | 56.73M | 1.19M | 552.21K | 125.24K | 6.35M | 1.56M | 11.22M |
| Long-Term Debt | 0 | 182.49K | 0 | 0 | 4.26M | 0 | 3.18M |
| Capital Lease Obligations | 1.24M | 809.09K | 402.42K | 28.58K | 2.04M | 1.52M | 1.03M |
| Deferred Tax Liabilities | 0 | 0 | 20.38M | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 55.49M | 197.87K | 149.79K | 96.66K | 54.94K | 39.61K | 7.01M |
| Total Liabilities | 58.02M | 4.08M | 2.24M | 1.65M | 9.4M | 10.14M | 14.85M |
| Total Debt | 1.71M | 2.06M | 990.21K | 543.72K | 6.7M | 7.44M | 4.7M |
| Net Debt | -4.7M | -1.27M | -23.79M | -12.42M | -15.02M | 3.99M | -4.57M |
| Debt / Equity | - | 0.58x | 0.04x | 0.04x | 0.37x | 3.23x | 0.80x |
| Debt / EBITDA | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - |
| Interest Coverage | -1129.06x | -549.72x | -390.86x | -844.80x | -85.12x | -10.73x | -8.85x |
| Total Equity | -45.37M▲ 0% | 3.53M▲ 107.8% | 26.33M▲ 646.4% | 15.24M▼ 42.1% | 18.35M▲ 20.4% | 2.3M▼ 87.4% | 5.87M▲ 154.7% |
| Equity Growth % | - | 107.78% | 646.39% | -42.11% | 20.4% | -87.44% | 154.7% |
| Book Value per Share | -3.86 | 0.30 | 2.23 | 1.29 | 1.19 | 0.10 | 0.15 |
| Total Shareholders' Equity | -45.37M | 3.53M | 26.33M | 15.24M | 18.35M | 2.3M | 5.87M |
| Common Stock | 1.06K | 1.11K | 11.92K | 11.99K | 21.77K | 23.47K | 59.72K |
| Retained Earnings | -68.29M | -75.2M | -82.74M | -94.13M | -108.38M | -127.2M | -145.83M |
| Treasury Stock | -60K | -60K | -60K | -60K | -60K | -60K | -60K |
| Accumulated OCI | 20 | 702.49K | 702.49K | 567.97K | 2.79M | 1.86M | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
FEMY Cash Flow Statement
Femasys Inc. (FEMY) cash flow — operating, investing & free cash flow history
| Line item | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|
| Cash from Operations | -11.01M | -4.93M | -7.93M | -10.73M | -11.28M | -19.44M | -18.69M |
| Operating CF Margin % | -1184.63% | -475.28% | -672.28% | -889.72% | -1052.32% | -1193.54% | -815% |
| Operating CF Growth % | - | 55.18% | -60.77% | -35.32% | -5.11% | -72.37% | 3.87% |
| Net Income | -11.27M | -6.91M | -7.54M | -11.39M | -14.25M | -18.82M | -18.63M |
| Depreciation & Amortization | 1.09M | 1.1M | 964.29K | 889.14K | 907.99K | 872K | 804.28K |
| Stock-Based Compensation | 358.84K | 318.64K | 193.37K | 224.94K | 675.7K | 444.15K | 790.14K |
| Deferred Taxes | 0 | 0 | 3.64K | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -107.17K | 4.61K | -821.51K | 6.38K | 161.39K | 1.2M | 399.74K |
| Working Capital Changes | -1.08M | 557.96K | -732.72K | -458.27K | 1.22M | -3.14M | -2.06M |
| Change in Receivables | 3.26K | -42.24K | 41.53K | 6.79K | -21.44K | 8K | -128.23K |
| Change in Inventory | -34.73K | 35.32K | -77.43K | -232.55K | -236.28K | -2.38M | -2.69M |
| Change in Payables | -13.93K | 80.75K | -228.81K | 65.24K | 627.07K | 207.48K | 334.83K |
| Cash from Investing | 12.32M | 968.32K | -306.87K | -407.48K | -143.92K | -847.76K | -630.1K |
| Capital Expenditures | -696.5K | -8.35K | -306.87K | -407.48K | -143.92K | -761.71K | -525.01K |
| CapEx % of Revenue | 74.97% | 0.8% | 26.01% | 33.78% | 13.43% | 46.76% | 22.89% |
| Acquisitions | 103.14K | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - |
| Other Investing | -103.14K | -23.33K | 0 | 0 | 0 | -86.06K | -105.09K |
| Cash from Financing | -127.78K | 871.65K | 29.7M | -681.64K | 20.18M | 2.03M | 25.14M |
| Debt Issued (Net) | -113.33K | 793.45K | -462.95K | -505.2K | 6.22M | 0 | 4.15M |
| Equity Issued (Net) | 2.63K | 153.2K | 31.74M | 59.58K | 11.56M | 2.03M | 22.93M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -17.07K | -75K | -1.58M | -236.02K | 2.39M | 2.35K | -1.95M |
| Net Change in Cash | 1.18M▲ 0% | -3.09M▼ 361.3% | 21.46M▲ 793.8% | -11.82M▼ 155.1% | 8.75M▲ 174.1% | -18.26M▼ 308.6% | 5.81M▲ 131.8% |
| Free Cash Flow | -11.7M▲ 0% | -4.96M▲ 57.6% | -8.24M▼ 65.9% | -11.14M▼ 35.2% | -11.42M▼ 2.6% | -20.21M▼ 76.9% | -19.22M▲ 4.9% |
| FCF Margin % | -1259.6% | -478.33% | -698.29% | -923.5% | -1065.74% | -1240.29% | -837.9% |
| FCF Growth % | - | 57.58% | -65.92% | -35.23% | -2.56% | -76.86% | 4.9% |
| FCF per Share | -0.99 | -0.42 | -0.70 | -0.94 | -0.74 | -0.91 | -0.49 |
| FCF Conversion (FCF/Net Income) | 0.98x | 0.71x | 1.05x | 0.94x | 0.79x | 1.03x | 1.00x |
| Interest Paid | 0 | 8.9K | 15.87K | 13.46K | 9.9K | 111K | 8.62K |
| Taxes Paid | 0 | 0 | 800 | 5.05K | 4.55K | 5.71K | 6.81K |
FEMY Key Ratios
Femasys Inc. (FEMY) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | -196.01% | -50.49% | -54.81% | -84.82% | -182.18% | -455.8% |
| Return on Invested Capital (ROIC) | - | -229.94% | -260.47% | -324.4% | -353.19% | -276.97% | -347.38% |
| Gross Margin | 75.92% | 70.47% | 68.6% | 63.36% | 64.54% | 66.55% | 61.96% |
| Net Margin | -1213.26% | -666.24% | -638.97% | -944.62% | -1329.06% | -1155.03% | -812.27% |
| Debt / Equity | - | 0.58x | 0.04x | 0.04x | 0.37x | 3.23x | 0.80x |
| Interest Coverage | -1129.06x | -549.72x | -390.86x | -844.80x | -85.12x | -10.73x | -8.85x |
| FCF Conversion | 0.98x | 0.71x | 1.05x | 0.94x | 0.79x | 1.03x | 1.00x |
| Revenue Growth | - | 11.72% | 13.66% | 2.25% | -11.13% | 51.97% | 40.77% |
FEMY SEC Filings & Documents
Femasys Inc. (FEMY) SEC filings — annual & quarterly reports (10-K, 10-Q)
FEMY Frequently Asked Questions
Femasys Inc. (FEMY) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Femasys Inc. (FEMY) reported $2.3M in revenue for fiscal year 2025. This represents a 147% increase from $0.9M in 2019.
Femasys Inc. (FEMY) grew revenue by 40.8% over the past year. This is strong growth.
Femasys Inc. (FEMY) reported a net loss of $18.6M for fiscal year 2025.
Dividend & Returns
Femasys Inc. (FEMY) has a return on equity (ROE) of -455.8%. Negative ROE indicates the company is unprofitable.
Femasys Inc. (FEMY) had negative free cash flow of $19.2M in fiscal year 2025, likely due to heavy capital investments.
Explore More FEMY
Femasys Inc. (FEMY) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates